FAF-21544-02401
4 vaccinations
7 coded responses
18 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 180 / PA
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Pfizer-BioNTech
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Health check-in — day 0, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia, Myoclonus — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Insomnia, myoclonic jerksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-15
Survey response — day 7, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Extreme menstrual pain and heavy flowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — day 14, dose 2MedDRA: Abnormal menstrual clots, Arthralgia, Bone pain, Migraine, Myalgia, Weight decreased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased menstrual clotting mid cycle; decreased appetite; weight loss; migraine; joint, bone, and muscle pain from fibromyalgiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — day 21, dose 2MedDRA: Fatigue, Office visit — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Extreme fatigue; low iron · Healthcare visit (other): In-person private appointmentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-06
-
2021-05-13
Survey response — day 35, dose 2MedDRA: Iron deficiency anaemia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: IDA and symptoms from venofer infusionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — day 42, dose 2MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Continued IDA and reax to Venofer infusionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-08
- 2021-10-07
-
2021-11-10
Dose 3 — Moderna
- 2022-04-07
- 2022-04-08
-
2022-09-20
Dose 4 — Janssen/Johnson & Johnson
-
2022-12-20
Survey response — 3 months, dose 4MedDRA: Hysterectomy, Salpingectomy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Abnormal menstrual bleeding resulting in hysterectomy with bilateral salpingectomyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-12-21
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Moderna | No |
| 4 | 2022-09-20 | Janssen/Johnson & Johnson | No |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia, myoclonic jerks
Release 7 — day 7, dose 2
Systemic reaction (other): Extreme menstrual pain and heavy flow
Release 7 — day 14, dose 2
Symptoms: Increased menstrual clotting mid cycle; decreased appetite; weight loss; migraine; joint, bone, and muscle pain from fibromyalgia
Release 8 — day 21, dose 2
Symptoms: Extreme fatigue; low iron
Healthcare visit (other): In-person private appointment
Release 8 — day 35, dose 2
Symptoms: IDA and symptoms from venofer infusions
Release 8 — day 42, dose 2
Symptoms: Continued IDA and reax to Venofer infusions
Release 12 — 3 months, dose 4
Symptoms: Abnormal menstrual bleeding resulting in hysterectomy with bilateral salpingectomy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Abnormal menstrual clots | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Bone pain | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hysterectomy | · | · | ✓ |
| SD | Iron deficiency anaemia | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Salpingectomy | · | · | ✓ |
| SD | Weight decreased | ✓ | ✓ | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Myoclonus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release